Moreover, 48.4% had hypertension, 29.2% fasting hypertriglyceridemia, 18.2% increased total cholesterol, 20.3% increased LDL cholesterol, 26.0% decreased HDL cholesterol, 81.4% increased HOMA-IR, 41.1% increased fasting insulin, and 35.6% impaired glucose metabolism. This evidence concerns the gene INS and Hypertension.